WITHDRAWN: Expression profiles and biological implications of plasma miRNAs associated with chronic myeloid leukemia phases
Ji Zhang,Yawen Jiang,Xu Han,Wenen Liu,Xielan Zhao,Jing Liu
DOI: https://doi.org/10.18632/oncotarget.23772
2018-01-01
Oncotarget
Abstract:// Ji Zhang 1, 2 , Yawen Jiang 1 , Xu Han 1 , Wenen Liu 3 , Xielan Zhao 4 and Jing Liu 1 1 Molecular Biology Research Center, School of Life Sciences, Central South University, Changsha 410078, China 2 Department of Hematology, The First Affiliated Hospital, University of South China, Hengyang 421001, China 3 Department of Clinical Laboratory, Xiangya Hospital of Central South University, Changsha, 410008, China 4 Department of Hematology, Xiangya Hospital of Central South University, Changsha, 410008, China Correspondence to: Jing Liu, email: jingliucsu@hotmail.com, liujing2@sklmg.edu.cn Ji Zhang, email: zhang_ji001@hotmail.com Keywords: plasma miRNA; chronic myeloid leukemia; expression profile; biological function; miR-451a Received: September 13, 2017 Accepted: November 16, 2017 Published: January 02, 2018 ABSTRACT microRNAs play important regulatory roles in hematologic malignancies, and dysregulation of circulating miRNAs serves as diagnostic, prognostic and predictive biomarkers in many diseases. The correlation of plasma miRNA profiles with the progression of chronic myeloid leukemia (CML) has not been investigated. We have applied microarrays to identify differentially expressed miRNAs, followed by qRT-PCR to validate candidate miRNAs from four sample pools including chronic phase (CP), accelerated phase(AP), blast crisis(BC) and healthy control. Clustering analyses revealed varying phase-specific patterns of plasma miRNA expression during CML progression. Different phases of CML showed differential expression profiles between sample pools during the progression. The functional annotation tool, DAVID, found that putative targets of dysregulated miRNAs in different phases of diease are involved in several important signaling pathways. Gradually decreased expression levels of miR-451a were validated in CML patients from the CP to AP and BC; when CML patients achieved major molecular response (MMR), miR-451a expression was increased and restored to normal range. These data provide an important resource for studies on CML progression and allow a better understanding of the fundamental differences in plasma miRNA expression profiles among the different phases of CML.